Oxidative stress and regulation of pink1 in zebrafish (Danio rerio)

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Priyadarshini, Madhusmita ^a   Orosco, Lori A ^b,c   Panula, Pertti J ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b GEOPHYSICAL LABORATORY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE; HYDROGEN PEROXIDE; MESSENGER RNA; PROTEIN KINASE; PTEN INDUCED PUTATIVE KINASE; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; EMBRYO; EXPOSURE; FLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PINK1 GENE; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENE; WILD TYPE; ZEBRA FISH;

ANIMALS; HYDROGEN PEROXIDE; OXIDATIVE STRESS; PROTEIN-SERINE-THREONINE KINASES; TYROSINE 3-MONOOXYGENASE; ZEBRAFISH;

EID: 84896707109     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081851     Document Type: Article

References (46)

1. Haavik J, Toska K (1998) Tyrosine hydroxylase and parkinson's disease. Mol Neurobiol 16: 285-309. doi:10.1007/BF02741387. PubMed: 9626667. (Pubitemid 28268547)
2. Singleton AB, Farrer MJ, Bonifati V (2013) The genetics of parkinson's disease: Progress and therapeutic implications. Mov Disord 28: 14-23. doi:10.1002/mds.25249. PubMed: 23389780.
3. Nicklas WJ, Youngster SK, Kindt MV, Heikkila RE (1987) MPTP, MPP+ and mitochondrial function. Life Sci 40: 721-729. doi:10.1016/0024-3205(87)90299-2. PubMed: 3100899.
4. Onyango IS (2008) Mitochondrial dysfunction and oxidative stress in parkinson's disease. Neurochem Res 33: 589-597. doi:10.1007/s11064-007-9482-y. PubMed: 17940895.
5. Bové J, Perier C (2012) Neurotoxin-based models of parkinson's disease. Neuroscience 211: 51-76. doi:10.1016/j.neuroscience.2011.10.057. PubMed: 22108613.
6. Santos D, Cardoso SM (2012) Mitochondrial dynamics and neuronal fate in parkinson's disease. Mitochondrion 12: 428-437. doi:10.1016/j.mito.2012.05.002. PubMed: 22609323.
7. Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K et al. (2004) Hereditary early-onset parkinson's disease caused by mutations in PINK1. Science 304: 1158-1160. doi:10.1126/science.1096284. PubMed: 15087508. (Pubitemid 38661852)
8. Klein C, Lohmann-Hedrich K, Rogaeva E, Schlossmacher MG, Lang AE (2007) Deciphering the role of heterozygous mutations in genes associated with parkinsonism. Lancet Neurol 6: 652-662. doi:10.1016/S1474-4422(07)70174-6. PubMed: 17582365. (Pubitemid 46921058)
9. Unoki M, Nakamura Y (2001) Growth-suppressive effects ofBPOZandEGR2, two genes involved in thePTENsignaling pathway. Oncogene 20: 4457-4465. doi:10.1038/sj.onc.1204608. PubMed: 11494141. (Pubitemid 32772428)
10. Silvestri L, Caputo V, Bellacchio E, Atorino L, Dallapiccola B et al. (2005) Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism. Hum Mol Genet 14: 3477-3492. doi:10.1093/hmg/ddi377. PubMed: 16207731. (Pubitemid 41672130)
11. Yang Y, Ouyang Y, Yang L, Beal MF, McQuibban A et al. (2008) Pink1 regulates mitochondrial dynamics through interaction with the fission/fusion machinery. Proc Natl Acad Sci U S A 105: 7070-7075. doi:10.1073/pnas.0711845105. PubMed: 18443288. (Pubitemid 351754531)
12. Gautier CA, Kitada T, Shen J (2008) Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress. Proc Natl Acad Sci U S A 105: 11364-11369. doi:10.1073/pnas.0802076105. PubMed: 18687901.
13. Priyadarshini M, Tuimala J, Chen YC, Panula P (2013) A zebrafish model of PINK1 deficiency reveals key pathway dysfunction including HIF signaling. Neurobiol Dis 54: 127-138. doi:10.1016/j.nbd.2013.02.002. PubMed: 23454196.
14. Atakisi O, Erdogan HM, Atakisi E, Citil M, Kanici A et al. (2010) Effects of reduced glutathione on nitric oxide level, total antioxidant and oxidant capacity and adenosine deaminase activity. Eur Rev Med Pharmacol Sci 14: 19-23. PubMed: 20184085.
15. Jenner P (1989) Clues to the mechanism underlying dopamine cell death in parkinson's disease. J Neurol Neurosurg Psychiatry, Suppl: 22-28 PubMed: 2666576.
16. Sallinen V, Kolehmainen J, Priyadarshini M, Toleikyte G, Chen YC et al. (2010) Dopaminergic cell damage and vulnerability to MPTP in Pink1 knockdown zebrafish. Neurobiol Dis 40: 93-101. doi:10.1016/j.nbd.2010.06.001. PubMed: 20600915.
17. Iida A, Tachibana A, Hamada S, Hori H, Koga A (2004) Low transposition frequency of the medaka fish Tol2 element may be due to extranuclear localization of its transposase. Genes Genet Syst 79: 119-124. doi:10.1266/ggs.79.119. PubMed: 15215677. (Pubitemid 38855837)
18. Eriksson KS, Peitsaro N, Karlstedt K, Kaslin J, Panula P (1998) Development of the histaminergic neurons and expression of histidine decarboxylase mRNA in the zebrafish brain in the absence of all peripheral histaminergic systems. Eur J Neurosci 10: 3799-3812. doi:10.1046/j.1460-9568. 1998.00394.x. PubMed: 9875358. (Pubitemid 29073936)
19. Kaslin J, Panula P (2001) Comparative anatomy of the histaminergic and other aminergic systems in zebrafish (danio rerio). J Comp Neurol 440: 342-377. doi:10.1002/cne.1390. PubMed: 11745628. (Pubitemid 33041750)
20. Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF (1995) Stages of embryonic development of the zebrafish. Dev Dyn 203: 253-310. doi:10.1002/aja.1002030302. PubMed: 8589427.
21. Fisher S, Grice EA, Vinton RM, Bessling SL, Urasaki A et al. (2006) Evaluating the biological relevance of putative enhancers using Tol2 transposon-mediated transgenesis in zebrafish. Nat Protoc 1: 1297-1305. doi:10.1038/nprot.2006.230. PubMed: 17406414.
22. Kawakami K (2007) Tol2: A versatile gene transfer vector in vertebrates. Genome Biol 8 Suppl 1: S7. doi:10.1186/gb-2007-8-1-r7. PubMed: 18047699.
23. Kwan KM, Fujimoto E, Grabher C, Mangum BD, Hardy ME et al. (2007) The Tol2kit: A multisite gateway-based construction kit for Tol2 transposon transgenesis constructs. Dev Dyn 236: 3088-3099. doi:10.1002/dvdy.21343. PubMed: 17937395. (Pubitemid 350175006)
24. Kaslin J, Nystedt JM, Ostergård M, Peitsaro N, Panula P (2004) The orexin/hypocretin system in zebrafish is connected to the aminergic and cholinergic systems. J Neurosci 24: 2678-2689. doi:10.1523/JNEUROSCI.4908-03. 2004. PubMed: 15028760. (Pubitemid 38380944)
25. Thisse C, Thisse B (2008) High-resolution in situ hybridization to whole-mount zebrafish embryos. Nat Protoc 3: 59-69. doi:10.1038/nnano.2008.25. PubMed: 18193022.
26. Chen YC, Priyadarshini M, Panula P (2009) Complementary developmental expression of the two tyrosine hydroxylase transcripts in zebrafish. Histochem Cell Biol 132: 375-381. doi:10.1007/s00418-009-0619-8. PubMed: 19603179.
27. Priyadarshini M, Tuimala J, Chen YC, Panula P (2013) A zebrafish model of PINK1 deficiency reveals key pathway dysfunction including HIF signaling. Neurobiol Dis 54: 127-138. doi:10.1016/j.nbd.2013.02.002. PubMed: 23454196.
28. Sallinen V, Sundvik M, Reenilä I, Peitsaro N, Khrustalyov D et al. (2009) Hyperserotonergic phenotype after monoamine oxidase inhibition in larval zebrafish. J Neurochem 109: 403-415. doi:10.1111/j.1471-4159.2009.05986.x. PubMed: 19222706.
29. Filippi A, Mahler J, Schweitzer J, Driever W (2010) Expression of the paralogous tyrosine hydroxylase encoding genes th1 and th2 reveals the full complement of dopaminergic and noradrenergic neurons in zebrafish larval and juvenile brain. J Comp Neurol 518: 423-438. doi:10.1002/cne.22213. PubMed: 20017209.
30. Mills RD, Sim CH, Mok SS, Mulhern TD, Culvenor JG et al. (2008) Biochemical aspects of the neuroprotective mechanism of PTEN-induced kinase-1 (PINK1). J Neurochem 105: 18-33. doi:10.1111/j.1471-4159.2008.05249.x. PubMed: 18221368. (Pubitemid 351441646)
31. Petit A, Kawarai T, Paitel E, Sanjo N, Maj M et al. (2005) Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by parkinson disease-related mutations. J Biol Chem 7: 280. PubMed: 16079129.
32. Mosimann C, Kaufman CK, Li P, Pugach EK, Tamplin OJ et al. (2011) Ubiquitous transgene expression and cre-based recombination driven by the ubiquitin promoter in zebrafish. Development 138: 169-177. doi:10.1242/dev. 059345. PubMed: 21138979.
33. Yoshinari N, Ando K, Kudo A, Kinoshita M, Kawakami A (2012) Colored medaka and zebrafish: Transgenics with ubiquitous and strong transgene expression driven by the medaka beta-actin promoter. Dev Growth Differ 54: 818-828. doi:10.1111/dgd.12013. PubMed: 23157381.
34. Taymans JM, Van den Haute C, Baekelandt V (2006) Distribution of PINK1 and LRRK2 in rat and mouse brain. J Neurochem 98: 951-961. doi:10.1111/j.1471- 4159.2006.03919.x. PubMed: 16771836.
35. Blackinton JG, Anvret A, Beilina A, Olson L, Cookson MR et al. (2007) Expression of PINK1 mRNA in human and rodent brain and in parkinson's disease. Brain Res 1184: 10-16. doi:10.1016/j.brainres.2007.09.056. PubMed: 17950257. (Pubitemid 350161884)
36. Bretaud S, MacRaild S, Ingham PW, Bandmann O (2011) The influence of the zebrafish genetic background on parkinson's disease-related aspects. Zebrafish 8: 103-108. doi:10.1089/zeb.2011.0697. PubMed: 21745139.
37. Chien WL, Lee TR, Hung SY, Kang KH, Lee MJ et al. (2011) Impairment of oxidative stress-induced heme oxygenase-1 expression by the defect of parkinson-related gene of PINK1. J Neurochem 117: 643-653. PubMed: 21366594.
38. Pridgeon JW, Olzmann JA, Chin LS, Li L (2007) PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1. PLoS Biol 5: e172. doi:10.1371/journal.pbio.0050172. PubMed: 17579517.
39. Kishi S, Bayliss PE, Uchiyama J, Koshimizu E, Qi J et al. (2008) The identification of zebrafish mutants showing alterations in senescence-associated biomarkers. PLoS Genet 4: e1000152. PubMed: 18704191.
40. Candy J, Collet C (2005) Two tyrosine hydroxylase genes in teleosts. Biochim Biophys Acta 1727: 35-44. doi:10.1016/j.bbaexp.2004.11.005. PubMed: 15652156. (Pubitemid 40093501)
41. Yamamoto K, Ruuskanen JO, Wullimann MF, Vernier P (2010) Two tyrosine hydroxylase genes in vertebrates: New dopaminergic territories revealed in the zebrafish brain. Mol Cell Neurosci 43: 394-402. doi:10.1016/j.mcn.2010.01.006. PubMed: 20123022.
42. Steele SL, Ekker M, Perry SF (2011) Interactive effects of development and hypoxia on catecholamine synthesis and cardiac function in zebrafish (danio rerio). J Comp Physiol B, 181: 527-38. PubMed: 21197535.
43. Ren G, Li S, Zhong H, Lin S (2013) Zebrafish tyrosine hydroxylase 2 gene encodes tryptophan hydroxylase. J Biol Chem, 288: 22451-9. PubMed: 23754283.
44. Meister A, Anderson ME (1983) Glutathione. Annu Rev Biochem 52: 711-760. doi:10.1146/annurev.bi.52.070183.003431. PubMed: 6137189. (Pubitemid 13030692)
45. Kari G, Rodeck U, Dicker AP (2007) Zebrafish: An emerging model system for human disease and drug discovery. Clin Pharmacol Ther 82: 70-80. doi:10.1038/sj.clpt.6100223. PubMed: 17495877. (Pubitemid 46944200)
46. Bandmann O, Burton EA (2010) Genetic zebrafish models of neurodegenerative diseases. Neurobiol Dis 40: 58-65. doi:10.1016/j.nbd.2010.05. 017. PubMed: 20493258.